Takeda Pharmaceuticals International

• NCT03106597

  Collaborator, Phase 4, Terminated, 46 people, 10 Apr 2017

• Intensive versus standard blood pressure control and overall brain small vessel disease burden: a post-hoc analysis of the SPRINT randomized clinical trial

  11 Aug 2026

Sources: api.crossref.org

• Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial

  Fees or honoraria, 13 Apr 2021

Sources: pubmed.ncbi.nlm.nih.gov